• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Kyowa Hakko Kirin Co Ltd

+ Add to Watchlist


9.462 EUR 0.009 0.10%

As of 04:55:03 ET on 09/19/2014.

Snapshot for Kyowa Hakko Kirin Co Ltd (KY4)

Open: 9.442 Day's Range: 9.429 - 9.688 Volume: 0
Previous Close: 9.471 52wk Range: 7.021 - 10.465 1-Yr Rtn: +31.54%

Stock Chart for KY4

No chart data available.
  • KY4:GR 9.462
  • 1D
  • 1M
  • 1Y
Interactive KY4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KY4

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 35.5383
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (12/2014) 37.2290
Est. PEG Ratio -
Market Cap (M EUR) 5,454.69
Shares Outstanding (M) 576.48
30 Day Average Volume 9
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.89%
Cash Dividend (JPY) 12.5000
Dividend Ex-Date 12/26/2014
5 Year Dividend Growth 4.97%
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KY4

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for KY4

Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.

Nobuo HanaiPresidentHiroyuki KawaiExecutive Vice President
Kazuyoshi TachibanaManaging Executive OfficerToshifumi MikayamaManaging Executive Officer
More Company Profile & Key Executives for KY4

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil